Assessing SMX (Security Matters) (NasdaqCM:SMX) Valuation After The TruCotton Traceability Alliance News

Advertisement

Why the TruCotton alliance matters for SMX shareholders

SMX (Security Matters) (NasdaqCM:SMX) is drawing attention after announcing a collaboration with TruCotton, a U.S. cotton traceability program, to apply its molecular marker technology to authenticate U.S. grown cotton across the supply chain.

The initiative is designed to let the cotton itself carry proof of origin through secure molecular tags that can be checked at multiple points. This replaces traditional documentation based approaches with machine readable evidence that links physical fibres to digital records.

See our latest analysis for SMX (Security Matters).

At a share price of $15.83, SMX has seen very sharp short term interest, with an 89.6% 1 day share price return. However, its 1 year total shareholder return of 99.8% decline and year to date share price return of 23.3% decline indicate that longer term momentum has been fading.

If this TruCotton news has you thinking about where else traceability and automation might matter, it could be a good moment to scan our list of 28 robotics and automation stocks as potential ideas beyond SMX.

With the share price whipsawing between very sharp one-day gains and multi-year declines, the real question is whether SMX is still being valued on promise alone or if the TruCotton story is already fully reflected in the price?

Preferred Price-to-Book of 101.2x: Is it justified?

At a last close of $15.83, SMX is trading on a P/B ratio of 101.2x, which is very high compared with both its industry and direct peers.

P/B compares a company’s market value to its book value, so a ratio of 101.2x suggests the market is paying far more than the accounting value of SMX’s net assets. For a business with $0 revenue and ongoing losses of $44.037m, that kind of premium places a lot of weight on future potential rather than current fundamentals.

Against the wider US Electronic industry P/B of 2.7x and a peer average of 4.9x, SMX’s valuation stands out as extremely rich. For the gap to close, either the company’s balance sheet and earnings profile would need to shift meaningfully, or the share price would need to adjust closer to levels more in line with those benchmarks.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-book of 101.2x (OVERVALUED)

However, you still have clear risks here, including zero revenue, ongoing losses of $44.037m and a very high 101.2x P/B multiple if sentiment turns.

Find out about the key risks to this SMX (Security Matters) narrative.

Build Your Own SMX (Security Matters) Narrative

If you look at these numbers and feel you see a different story, the best step is to check the data yourself and shape your own thesis, then Do it your way.

A great starting point for your SMX (Security Matters) research is our analysis highlighting 4 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If you are serious about upgrading your watchlist, do not stop at SMX, use the Simply Wall St screener to uncover other opportunities that might better fit your approach.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqCM:SMX

SMX (Security Matters)

Provides brand protection, authentication and track and trace technology for the anti-counterfeit market.

Medium-low risk with mediocre balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
48 users have followed this narrative
2 users have commented on this narrative
8 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7720.1% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
83 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
190 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0